# EDGAR Filing Document

**Accession Number:** 0001279695
**File Stem:** 0001279695-25-000005
**Filing Date:** 2025-11
**Character Count:** 2882
**Document Hash:** 2fcd2e78bc5a8fea1fb3b28879cf8d4f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001279695-25-000005.hdr.sgml**: 20251117

**ACCESSION NUMBER**: 0001279695-25-000005

**CONFORMED SUBMISSION TYPE**: 15-12G

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251117

**DATE AS OF CHANGE**: 20251114

**EFFECTIVENESS DATE**: 20251117

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** UNIVERSAL BIOSENSORS INC
- **CENTRAL INDEX KEY:** 0001279695
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 980424072
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 15-12G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-52607
- **FILM NUMBER:** 251488863

**BUSINESS ADDRESS:**
- **STREET 1:** 1 CORPORATE AVENUE
- **STREET 2:** ROWVILLE
- **CITY:** VICTORIA
- **STATE:** C3
- **ZIP:** 3178
- **BUSINESS PHONE:** 613-921-9000

**MAIL ADDRESS:**
- **STREET 1:** 1 CORPORATE AVENUE
- **STREET 2:** ROWVILLE
- **CITY:** VICTORIA
- **STATE:** C3
- **ZIP:** 3178

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

__________________

**FORM 15** 

__________________

**CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION** 

**UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934** 

**OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)** 

**OF THE SECURITIES EXCHANGE ACT OF 1934.** 

**Commission File Number 000-52607**

__________________

**UNIVERSAL BIOSENSORS, INC.** 

**(Exact name of registrant as specified in its charter)** 

__________________

**1 Corporate Avenue**

**Rowville, 3178, Victoria**

**Australia**

**+61 3 9213 9000** 

**(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)** 

**Common Stock, $.0001 par value per share** 

**(Title of each class of securities covered by this Form)** 

**None.** 

**(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)** 

__________________

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

---

| | |
|:---|:---|
| Rule 12g-4(a)(1) | X |
| Rule 12g-4(a)(2) | ☐ |
| Rule 12h-3(b)(1)(i) | X |
| Rule 12h-3(b)(1)(ii) | ☐ |
| Rule 15d-6 | ☐ |
| Rule 15d-22(b) | ☐ |

---

Approximate number of holders of record as of the certification or notice date: One

Pursuant to the requirements of the Securities Exchange Act of 1934, Universal Biosensors, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

---

| | | |
|:---|:---|:---|
| Date: November 14, 2025 | By: | /s/ Peter Mullin |
|  | Name: | Peter Mullin |
|  | Title: | Chief Executive Officer |

---